Summary

Clinician-scientists hope to expand the use of blood-based biomarker tests for traumatic brain injury (TBI) to improve identification and escalation of care for patients whose diagnosis otherwise might be missed. In a study published in the Journal of Neurosurgery , a multi-institutional research team led by University of Pittsburgh School of Medicine neurosurgery clinician-scientists reports clinical cutoffs for two brain-associated proteins detected in the blood after brain injury that may help better identify and triage patients with TBI.

AI summaries can be wrong sometimes—always verify important details using the source article.